Jeffrey Shenberger

Dr. Jeffrey Shenberger

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
PGParvesh Mohan Garg
Parvesh Mohan Garg
MDMcKenzie X Denton
McKenzie X Denton
SRSrikanth Ravisankar
Srikanth Ravisankar
MHMaja Herco
Maja Herco
JSJeffrey Shenberger
Jeffrey Shenberger
YCYan-Hua Chen
Yan-Hua Chen
The intestinal epithelial barrier consists of a single layer of cells that separate the gut lumen from the rest of the body. It regulates and protects the intestinal tract immunologically and mechanically. Necrotizing enterocolitis (NEC) is one of the most common conditions requiring emergency surgery in the neonatal intensive care unit and is associated with a septic shock-like state contributing to multi-organ dysfunction. NEC affects 6–10% of very low birthweight infants and remains a leading cause of death. This review presents current evidence of the role of tight junction proteins in clinical neonatology and intestinal health using information from our own clinical and laboratory research in conjunction with information collected from an extensive search in the databases PubMed, EMBASE, and Scopus. The ability to measure the permeability of the intestinal barrier in real-time is essential to understanding the disease process of NEC and the subsequent morbidities. Detection of TJ proteins in blood and stool of preterm infants represents a potential biomarker for the early NEC diagnosis. Therapeutics targeting TJ proteins may also mitigate NEC severity and improve clinical outcomes.

8 March 2024 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
VCVilmaris Quinones Cardona
Vilmaris Quinones Cardona
SCSusan Cohen
Susan Cohen
NCNoah Cook
Noah Cook
MCMehmet Cizmeci
Mehmet Cizmeci
ACAMIT CHANDEL
AMIT CHANDEL
MDMaria L V Dizon
Maria L V Dizon
Objective This study aimed to determine neonatal neurodevelopmental follow-up (NDFU) practices across academic centers. Study Design This study was a cross-sectional survey that addressed center-specific neonatal NDFU practices within the Children's Hospitals Neonatal Consortium (CHNC). Results Survey response rate was 76%, and 97% of respondents had a formal NDFU program. Programs were commonly staffed by neonatologists (80%), physical therapists (77%), and nurse practitioners (74%). Median gestational age at birth identified for follow-up was ≤32 weeks (range 26–36). Median duration was 3 years (range 2–18). Ninety-seven percent of sites used Bayley Scales of Infant and Toddler Development, but instruments used varied across ages. Scores were recorded in discrete electronic data fields at 43% of sites. Social determinants of health data were collected by 63%. Care coordination and telehealth services were not universally available. Conclusion NDFU clinics are almost universal within CHNC centers. Commonalities and variances in practice highlight opportunities for data sharing and development of best practices. Key Points

13 January 2026 in Journal of Neonatal-Perinatal Medicine
Verified
Journal Article
Closed access
DVDipen Vyas
Dipen Vyas
MRMenaka Reddy
Menaka Reddy
APAditya Patel
Aditya Patel
CMCaroline Minnick
Caroline Minnick
JSJeffrey Shenberger
Jeffrey Shenberger
PGParvesh Mohan Garg
Parvesh Mohan Garg
Background: Meta-analyses of observational studies evaluating association between blood transfusion and necrotizing enterocolitis (NEC) have shown mixed results and an independent association between anemia and NEC requires further evaluation. Objective: To investigate the association of NEC with anemia in preterm infants via meta-analysis of (1) randomized controlled trials (RCTs) evaluating transfusion thresholds and recombinant erythropoietin (rEpo)/darbepoetin and (2) case–control studies comparing hematocrit levels between NEC cases and controls. Data sources: PubMed, Embase, Scopus, and the Cochrane Database were searched in August 2025, and the results were supplemented by other sources. Study selection: (1) Transfusion threshold and rEpo RCTs evaluating NEC rates in preterm infants with lower hemoglobin (Hb) levels compared with higher Hb levels. (2) Case–control studies comparing hematocrit levels between NEC cases and controls. Primary outcome: The incidence of any stage NEC in infants with low versus high Hb group. Results: RCTs evaluating transfusion threshold (n = 4, 3307 participants) showed no difference in NEC incidence between the low versus high Hb group [OR: 1.14 (CI: 0.89, 1.46), p 0.647]. RCTs evaluating rEPO versus placebo ( n = 11, 4173 participants) showed higher incidence of NEC in the low versus high Hb group [OR: 1.43 (CI: 1.13, 1.80), p 0.003]. Meta-analysis of case–control studies ( n = 3, 1016 participants) showed association of lower hematocrit levels in NEC cases compared with controls (standardized mean difference −0.28; CI −0.56, −0.002; p 0.048). Conclusion: Our analysis suggests an association between NEC and lower hemoglobin levels. Well-designed and adequately powered prospective studies are required to confirm our findings.

3 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
UDUsha Devi
Usha Devi
JWJör̈n-Hendrik Weitkamp
Jör̈n-Hendrik Weitkamp
JSJeffrey Shenberger
Jeffrey Shenberger
PGParvesh Mohan Garg
Parvesh Mohan Garg
Necrotizing enterocolitis (NEC) remains one of the most devastating gastrointestinal emergencies in neonates and also presents major diagnostic challenges. Despite extensive research, NEC still lacks a practical definition and relies on a set of nonspecific clinical, laboratory, and radiological findings rather than a single pathognomonic presentation or test. The modified Bell staging system remains the most widely used framework in clinical practice and research, but it was originally developed to base the treatment decisions rather than helping in diagnosis and has important limitations when applied as a diagnostic aid. Clinical and radiological criteria used for early stages of NEC are nonspecific, progression of the disease is not always linear, radiographic signs are inconsistently present, and histopathological confirmation is unavailable in most of the cases as surgery is not undertaken in all the cases. These limitations have led to the opinion that even the modified Bell staging is “broken” when it is used to define the disease itself. At the same time, increased understanding about gut immunity and microbiome progression, and neonatal hemodynamics have made it increasingly clear that NEC is not a single uniform disease. It is now regarded as a heterogeneous syndrome comprising multiple phenotypes that share a final common pathway of intestinal injury and necrosis but differ in timing, predisposing factors, mechanisms involved, and clinical course. These presentations overlap with several neonatal conditions including spontaneous intestinal perforation, septic ileus, cow’s milk protein allergy, congenital heart disease-related intestinal hypoperfusion, viral enterocolitis, malrotation with volvulus, and intussusception. This review discusses controversies in the definition and staging of NEC, consolidates alternative diagnostic criteria proposed beyond Bell’s system, and elaborates a phenotype-based framework for clinical distinction. Also, the review throws light on the clinical mimickers, practical bedside diagnosis using serial clinical assessment and imaging, consequences of NEC, and emerging precision medicine approaches. A shift from stage-based labeling toward a practical, phenotype-informed framework may improve diagnostic precision, reduce misclassification, and enhance both clinical care and research.

29 May 2026 in Children
Verified
Journal Article
Open access
PDF file
UDUsha Devi
Usha Devi
JWJör̈n-Hendrik Weitkamp
Jör̈n-Hendrik Weitkamp
JSJeffrey Shenberger
Jeffrey Shenberger
PGParvesh Mohan Garg
Parvesh Mohan Garg
Necrotizing enterocolitis (NEC) remains one of the most devastating gastrointestinal emergencies in neonates and also presents major diagnostic challenges. Despite extensive research, NEC still lacks a practical definition and relies on a set of nonspecific clinical, laboratory, and radiological findings rather than a single pathognomonic presentation or test. The modified Bell staging system remains the most widely used framework in clinical practice and research, but it was originally developed to guide treatment decisions rather than aid diagnosis and has important limitations when applied as a diagnostic aid. Clinical and radiological criteria used for early stages of NEC are nonspecific, disease progression is not always linear, radiographic signs are inconsistently present, and histopathological confirmation is unavailable in most of the cases as surgery is not undertaken in all the cases. These limitations have led to the opinion that even the modified Bell staging is “broken” when it is used to define the disease itself. At the same time, increased understanding about gut immunity and microbiome progression, and neonatal hemodynamics make it increasingly clear that NEC is not a single uniform disease. It is now regarded as a heterogeneous syndrome comprising multiple phenotypes that share a final common pathway of intestinal injury and necrosis differing in timing, predisposing factors, mechanism, and clinical course. These presentations overlap with several neonatal conditions including spontaneous intestinal perforation, septic ileus, cow’s milk protein allergy, congenital heart disease-related intestinal hypoperfusion, viral enterocolitis, malrotation with volvulus, and intussusception. This review discusses controversies in the definition and staging of NEC, consolidates alternative diagnostic criteria beyond Bell’s system, and elaborates on a phenotype-based framework for clinical distinction. Also, the review sheds light on the clinical mimickers, practical bedside diagnosis using serial clinical assessment and imaging, consequences of NEC, and emerging precision medicine approaches. A shift from stage-based labeling toward a practical, phenotype-informed framework may improve diagnostic precision, reduce misclassification, and enhance both clinical care and research.